vs
Q32 Bio Inc.（QTTB）与Rithm Property Trust Inc.（RPT）财务数据对比。点击上方公司名可切换其他公司
Rithm Property Trust Inc.的季度营收约是Q32 Bio Inc.的1.8倍（$3.4M vs $1.9M），Q32 Bio Inc.净利率更高（2991.2% vs 95.4%，领先2895.8%）
Q32 Bio Inc.是一家处于临床阶段的生物技术企业，专注于研发针对自身免疫疾病、炎症性疾病及罕见免疫类疾病的靶向抗体免疫疗法，面向有未满足医疗需求的患者群体，核心业务覆盖北美与欧洲市场。
Rithm Property Trust Inc.旗下的里思资本是一家总部位于纽约的美国投资管理公司，核心业务聚焦于房地产投资及另类投资领域，是该赛道颇具影响力的专业投资机构。
QTTB vs RPT — 直观对比
营收规模更大
RPT
是对方的1.8倍
$1.9M
净利率更高
QTTB
高出2895.8%
95.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.9M | $3.4M |
| 净利润 | $57.7M | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 99.6% |
| 净利率 | 2991.2% | 95.4% |
| 营收同比 | — | -39.7% |
| 净利润同比 | 506.9% | 11.2% |
| 每股收益（稀释后） | $4.70 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QTTBRPT
| Q4 25 | $1.9M | $3.4M | ||
| Q3 25 | $-220.0K | $4.0M | ||
| Q2 25 | $-284.0K | $4.2M | ||
| Q1 25 | $-371.0K | $249.0K | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
净利润QTTBRPT
| Q4 25 | $57.7M | $3.2M | ||
| Q3 25 | $-7.4M | $-273.0K | ||
| Q2 25 | $-9.5M | $1.9M | ||
| Q1 25 | $-11.0M | $-3.4M | ||
| Q4 24 | $-14.2M | — | ||
| Q3 24 | $-17.6M | — | ||
| Q2 24 | $-17.0M | — | ||
| Q1 24 | $1.0M | — |
营业利润率QTTBRPT
| Q4 25 | — | 99.6% | ||
| Q3 25 | 3444.1% | -6.2% | ||
| Q2 25 | 3229.2% | 45.7% | ||
| Q1 25 | 3296.0% | -1416.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
净利率QTTBRPT
| Q4 25 | 2991.2% | 95.4% | ||
| Q3 25 | 3358.6% | -6.8% | ||
| Q2 25 | 3341.2% | 45.1% | ||
| Q1 25 | 2973.3% | -1363.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
每股收益（稀释后）QTTBRPT
| Q4 25 | $4.70 | $-0.26 | ||
| Q3 25 | $-0.60 | $-0.03 | ||
| Q2 25 | $-0.78 | $0.01 | ||
| Q1 25 | $-0.90 | $-0.08 | ||
| Q4 24 | $2.63 | — | ||
| Q3 24 | $-1.46 | — | ||
| Q2 24 | $-1.42 | — | ||
| Q1 24 | $-6.33 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $48.3M | $79.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $42.0M | $291.6M |
| 总资产 | $61.8M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资QTTBRPT
| Q4 25 | $48.3M | $79.3M | ||
| Q3 25 | $49.0M | $81.4M | ||
| Q2 25 | $54.8M | $98.6M | ||
| Q1 25 | $65.5M | $97.4M | ||
| Q4 24 | $78.0M | — | ||
| Q3 24 | $89.1M | — | ||
| Q2 24 | $97.7M | — | ||
| Q1 24 | $115.5M | — |
股东权益QTTBRPT
| Q4 25 | $42.0M | $291.6M | ||
| Q3 25 | $-18.4M | $291.7M | ||
| Q2 25 | $-12.2M | $294.7M | ||
| Q1 25 | $-4.0M | $296.1M | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $18.3M | — | ||
| Q2 24 | $33.5M | — | ||
| Q1 24 | $48.8M | — |
总资产QTTBRPT
| Q4 25 | $61.8M | $1.0B | ||
| Q3 25 | $57.8M | $1.0B | ||
| Q2 25 | $66.1M | $1.0B | ||
| Q1 25 | $79.1M | $1.0B | ||
| Q4 24 | $92.3M | — | ||
| Q3 24 | $104.5M | — | ||
| Q2 24 | $124.2M | — | ||
| Q1 24 | $152.3M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.2M | $-8.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.11× | -2.56× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流QTTBRPT
| Q4 25 | $-6.2M | $-8.3M | ||
| Q3 25 | $-4.2M | $-5.8M | ||
| Q2 25 | $-10.7M | $-25.0K | ||
| Q1 25 | $-12.5M | $-1.6M | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $-19.5M | — | ||
| Q2 24 | $-22.2M | — | ||
| Q1 24 | $-14.6M | — |
自由现金流QTTBRPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $-19.6M | — | ||
| Q2 24 | $-22.2M | — | ||
| Q1 24 | — | — |
资本支出强度QTTBRPT
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率QTTBRPT
| Q4 25 | -0.11× | -2.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.01× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -14.14× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
